Predicting naltrexone response in alcohol-dependent patients: The contribution of functional magnetic resonance imaging

Alcoholism: Clinical and Experimental Research

Volumn 38, Issue 11, 2014, Pages 2754-2762

  Mann, Karl ^a   Vollstädt Klein, Sabine ^a   Reinhard, Iris ^a   Leménager, Tagrid ^a   Fauth Bühler, Mira ^a   Hermann, Derik ^a   Hoffmann, Sabine ^a   Zimmermann, Ulrich S ^b   Kiefer, Falk ^a   Heinz, Andreas ^c   Smolka, Michael N ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acamprosate; Alcohol; Cue reactivity; fMRI; Naltrexone; Personalized medicine; Relapse

Indexed keywords

NALTREXONE; NARCOTIC ANTAGONIST;

ADULT; ALCOHOLISM; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOSTIMULATION; PREDICTIVE VALUE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ALCOHOLISM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PHOTIC STIMULATION; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 84911421918     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12546     Document Type: Article

References (56)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Author, Washington, DC.
2. Anton RF (2000) Obsessive-compulsive aspects of craving: development of the Obsessive Compulsive Drinking Scale. Addiction 95(Suppl 2):S211-S217.
3. Anton RF, Litten RZ, Falk DE, Palumbo JM, Bartus RT, Robinson RL, Kranzler HR, Kosten TR, Meyer RE, O'Brien CP, Mann K, Meulien D (2012) The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders. Neuropsychopharmacology 37:402-411.
4. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295:2003-2017.
5. Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H, Goldman D (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 65:135-144.
6. Bartholow BD, Lust SA, Tragesser SL (2010) Specificity of P3 event-related potential reactivity to alcohol cues in individuals low in alcohol sensitivity. Psychol Addict Behav 24:220-228.
7. Bohn MJ, Krahn DD, Staehler BA (1995) Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res 19:600-606.
8. Brett M, Anton JL, Valabregue R, Poline JB (2002) Region of interest analysis using an SPM toolbox. Neuroimage 16(Suppl 1): 1140-1141.
9. Bühler M, Mann K (2011) Alcohol and the human brain: a systematic review of different neuroimaging methods. Alcohol Clin Exp Res 35:1771-1793.
10. Drummond DC (2001) Theories of drug craving, ancient and modern. Addiction 96:33-46.
11. Grusser SM, Heinz A, Flor H (2000) Standardized stimuli to assess drug craving and drug memory in addicts. J Neural Transm 107:715-720.
12. Grüsser SM, Wrase J, Klein S, Hermann D, Smolka MN, Ruf M, Weber-Fahr W, Flor H, Mann K, Braus DF, Heinz A (2004) Cue-induced activation of the striatum and medial prefrontal cortex predicts relapse in abstinent alcoholics. Psychopharmacology 175:296-302.
13. Heilig M, Goldman D, Berrettini W, O'Brien CP (2011) Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci 12:670-684.
14. Heilig M, Thorsell A, Sommer WH, Hansson AC, Ramchandani VA, George DT, Hommer D, Barr CS (2010) Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci Biobehav Rev 35:334-344.
15. Heinz A (2002) Dopaminergic dysfunction in alcoholism and schizophrenia-psychopathological and behavioral correlates. Eur Psychiatry 17:9-16.
16. Hermann D, Smolka MN, Wrase J, Klein S, Nikitopoulos J, Georgi A, Braus DF, Flor H, Mann K, Heinz (2006) A blockade of cue-induced brain activation of abstinent alcoholics by a single administration of amisulpride as measured with fMRI. Alcohol Clin Exp Res 30:1349-1354.
17. Hermann D, Weber-Fahr W, Sartorius A, Hoerst M, Frischknecht U, Tunc-Skarka N, Perreau-Lenz S, Hansson AC, Krumm B, Kiefer F, Spanagel R, Mann K, Ende G, Sommer WH (2012) Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats. Biol Psychiatry 71:1015-1021.
18. Jupp B, Dalley JW (2014) Behavioral endophenotypes of drug addiction: etiological insights from neuroimaging studies. Neuropharmacology 76: 487-497.
19. Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217-238.
20. Kranzler HR, Edenberg HJ (2010) Pharmacogenetics of alcohol and alcohol dependence treatment. Curr Pharm Des 16:2141-2148.
21. Lang PJ, Bradley MM, Cuthbert BN (2008) International affective picture system (IAPS): affective ratings of pictures and instruction manual. Center for Research in Psychophysiology, University of Florida.
22. Langosch JM, Spiegelhalder K, Jahnke K, Feige B, Regen W, Kiemen A, Hennig J, Olbrich HM (2012) The impact of acamprosate on cue reactivity in alcohol dependent individuals: a functional magnetic resonance imaging study. J Clin Psychopharmacol 32:661-665.
23. Lingford-Hughes A, Nutt D (2003) Neurobiology of addiction and implications for treatment. Br J Psychiatry 182:97-100.
24. Litten RZ, Egli M, Heilig M, Cui C, Fertig JB, Ryan ML, Falk DE, Moss H, Huebner R, Noronha A (2012) Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol 17:513-527.
25. Loeber S, Vollstädt-Klein S, von der Goltz C, Flor H, Mann K, Kiefer F (2009) Attentional bias in alcohol-dependent patients: the role of chronicity and executive functioning. Addict Biol 14:194-203.
26. Maas LC, Lukas SE, Kaufman MJ, Weiss RD, Daniels SL, Rogers VW, Kukes TJ, Renshaw PF (1998) Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry 155:124-126.
27. Mann K, Ackermann K (2000) Die OCDS-G: psychometrische Kennwerte der deutschen Version der Obsessive Compulsive Drinking Scale [The OCDS-G: psychometric characteristics of the German Version of the Obsessive Compulsive Drinking Scale]. Sucht 46:90-100.
28. Mann K, Kiefer F, Smolka M, Gann H, Wellek S, Heinz A (2009) Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study. Alcohol Clin Exp Res 33:674-683.
29. Mann K, Lemenager T, Hoffmann S, Reinhard I, Hermann D, Batra A, Berner M, Wodarz N, Heinz A, Smolka MN, Zimmermann US, Wellek S, Kiefer F, Anton RF (2013) Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Addict Biol 18:937-946.
30. Miller MA, Fillmore MT (2011) Persistence of attentional bias toward alcohol-related stimuli in intoxicated social drinkers. Drug Alcohol Depend 117:184-189.
31. Miller WR, Del Boca FK (1994) Measurement of drinking behavior using the Form 90 family of instruments. J Stud Alcohol Suppl 12:112-118.
32. Monti PM, Rohsenow DJ, Hutchison KE (2000) Toward bridging the gap between biological, psychobiological and psychosocial models of alcohol craving. Addiction 95(Suppl 2):S229-S236.
33. Myrick H, Anton RF, Li X, Henderson S, Drobes D, Voronin K, George MS (2004) Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology 29:393-402.
34. Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K (2008) Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry 65:466-475.
35. Nielsen FA, Hansen LK (2002) Automatic anatomical labeling of Talairach coordinates and generation of volumes of interest via the BrainMap database. Neuroimage 16(Suppl 1): 1126-1128.
36. Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97-113.
37. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546-1552.
38. Ramchandani VA, Umhau J, Pavon FJ, Ruiz-Velasco V, Margas W, Sun H, Damadzic R, Eskay R, Schoor M, Thorsell A, Schwandt ML, Sommer WH, George DT, Parsons LH, Herscovitch P, Hommer D, Heilig M (2011) A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry 16:809-817.
39. Reinert DF, Allen JP (2002) The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research. Alcohol Clin Exp Res 26:272-279.
40. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247-291.
41. Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M (2010) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 12: CD001867.
42. Schacht JP, Anton RF, Myrick H (2013) Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol 18:121-133.
43. Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H (2011) Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach. Neuroimage 56:61-68.
44. Scheurich A, Muller MJ, Anghelescu I, Lorch B, Dreher M, Hautzinger M, Szegedi A (2005) Reliability and validity of the form 90 interview. Eur Addict Res 11:50-56.
45. Schoenmakers T, Wiers RW, Field M (2008) Effects of a low dose of alcohol on cognitive biases and craving in heavy drinkers. Psychopharmacology 197:169-178.
46. Skinner HA, Horner JL (1984) Alcohol Dependence Scale: User's Guide. Addiction Research Foundation, Toronto, ON.
47. Smolka MN, Bühler M, Klein S, Zimmermann U, Mann K, Heinz A, Braus DF (2006) Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery. Psychopharmacology 184:577-588.
48. Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura C, Magnone MC, Lascorz J, Depner M, Holzberg D, Soyka M, Schreiber S, Matsuda F, Lathrop M, Schumann G, Albrecht U (2005) The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med 11:35-42.
49. Sullivan EV, Harris RA, Pfefferbaum A (2010) Alcohol's effects on brain and behavior. Alcohol Res Health 33:127-143.
50. Vollstädt-Klein S, Loeber S, von der Goltz C, Mann K, Kiefer F (2009) Avoidance of alcohol-related stimuli increases during the early stage of abstinence in alcohol-dependent patients. Alcohol Alcohol 44:458-463.
51. Weiss F, Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP, Valdez GR, Ben Shahar O, Angeletti S, Richter RR (2001) Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann N Y Acad Sci 937:1-26.
52. Wiers RW, Rinck M, Dictus M, van den Wildenberg E (2009) Relatively strong automatic appetitive action-tendencies in male carriers of the OPRM1 G-allele. Genes Brain Behav 8:101-106.
53. van den Wildenberg E, Wiers RW, Dessers J, Janssen RG, Lambrichs EH, Smeets HJ, van Breukelen GJ (2007) A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers. Alcohol Clin Exp Res 31:1-10.
54. Wittchen HU, Zaudig M, Fydrich T (1997) Strukturiertes Klinisches Interview für DSM-IV (SKID-I und SKID-II) [The Structured Clinical Interview for DSM-IV (SCID-I and SCID II)]. Hogrefe, Göttingen.
55. Wrase J, Grüsser SM, Klein S, Diener C, Hermann D, Flor H, Mann K, Braus DF, Heinz A (2002) Development of alcohol-associated cues and cue-induced brain activation in alcoholics. Eur Psychiatry 17:287-291.
56. Yalachkov Y, Kaiser J, Naumer MJ (2012) Functional neuroimaging studies in addiction: multisensory drug stimuli and neural cue reactivity. Neurosci Biobehav Rev 36:825-835.